Matches in Wikidata for { <http://www.wikidata.org/entity/Q96811521> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- Q96811521 description "artículu científicu espublizáu en xunu de 2020" @default.
- Q96811521 description "scientific article published on 29 June 2020" @default.
- Q96811521 description "wetenschappelijk artikel" @default.
- Q96811521 description "наукова стаття, опублікована 29 червня 2020" @default.
- Q96811521 name "The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial" @default.
- Q96811521 name "The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial" @default.
- Q96811521 type Item @default.
- Q96811521 label "The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial" @default.
- Q96811521 label "The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial" @default.
- Q96811521 prefLabel "The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial" @default.
- Q96811521 prefLabel "The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial" @default.
- Q96811521 P1433 Q96811521-40801768-F175-48DE-A5FF-DED667B74F38 @default.
- Q96811521 P1476 Q96811521-950D7B2B-7F3E-4287-AD4A-5AF9EA9922F0 @default.
- Q96811521 P2093 Q96811521-174492D1-A466-49F4-8D88-F98D417138CD @default.
- Q96811521 P2093 Q96811521-1D30308A-AC5A-4744-A680-CF745EDB92A3 @default.
- Q96811521 P2093 Q96811521-24DB6376-56CC-4E18-95AB-67FFF2B47D3C @default.
- Q96811521 P2093 Q96811521-593A0E12-3B62-4FBD-9210-551438D043E0 @default.
- Q96811521 P2093 Q96811521-688EC8E8-171B-4FA6-95A4-5E8B46E108A4 @default.
- Q96811521 P2093 Q96811521-68B0BEFE-88BF-4A6B-A0BA-351614C73807 @default.
- Q96811521 P2093 Q96811521-6EAF1DD4-5821-4B0A-A9EF-EFD8A756806E @default.
- Q96811521 P2093 Q96811521-853F5D84-6BC8-4F54-B816-0FCB1CEEAC76 @default.
- Q96811521 P2093 Q96811521-8F4C2E75-9FE8-4BB8-867B-B8E5386D0539 @default.
- Q96811521 P2093 Q96811521-BC46A735-02D0-4206-A75A-F00301F8E7A8 @default.
- Q96811521 P2093 Q96811521-D21FFC9A-4161-436D-B5A8-62034A355F5C @default.
- Q96811521 P2093 Q96811521-D2C63750-FFF9-4175-A9C2-1D5FEC2494D6 @default.
- Q96811521 P2093 Q96811521-DC93A78B-3053-49D0-A456-A728C7CAA85B @default.
- Q96811521 P2093 Q96811521-F302B967-E9B5-4BBB-B4DE-9676BB13B878 @default.
- Q96811521 P2093 Q96811521-FDE3B4B6-7941-4DB6-A07D-86CBD95479B1 @default.
- Q96811521 P304 Q96811521-44ABFBD5-A8AF-4F9A-88B7-EA1B5A8974A2 @default.
- Q96811521 P31 Q96811521-0026CDA0-BCAD-4176-9105-57822279F006 @default.
- Q96811521 P356 Q96811521-FA7574FB-A67E-4747-A6E2-144C37744CFE @default.
- Q96811521 P433 Q96811521-C275A628-B245-466D-A36D-4FD5BC698B2F @default.
- Q96811521 P478 Q96811521-1BE44F0B-F73E-49FD-9F52-644FF0A9E873 @default.
- Q96811521 P577 Q96811521-BEE3DC46-C7A7-4536-949E-B73D711EC978 @default.
- Q96811521 P698 Q96811521-3C6B92AF-573B-4A60-95AF-C056EB533344 @default.
- Q96811521 P921 Q96811521-02579773-6993-479D-A4B5-6A0469641F17 @default.
- Q96811521 P921 Q96811521-96970A74-A9EE-4418-8948-9A6C9D8BFAA8 @default.
- Q96811521 P932 Q96811521-F338D15C-857C-4154-AA0D-556F9A3C4975 @default.
- Q96811521 P356 S13063-020-04517-6 @default.
- Q96811521 P698 32600454 @default.
- Q96811521 P1433 Q7840023 @default.
- Q96811521 P1476 "The TOTEM RRMS (Testosterone Treatment on neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis) trial: study protocol for a randomized, double-blind, placebo-controlled trial" @default.
- Q96811521 P2093 "Anne Kerbrat" @default.
- Q96811521 P2093 "Ayikoe-Guy Mensah-Nyagan" @default.
- Q96811521 P2093 "Dominique Bagnard" @default.
- Q96811521 P2093 "Eric Berger" @default.
- Q96811521 P2093 "Gilles Edan" @default.
- Q96811521 P2093 "Guillaume Mathey" @default.
- Q96811521 P2093 "Julien Lamy" @default.
- Q96811521 P2093 "Jérôme De Seze" @default.
- Q96811521 P2093 "Katline Metzger-Peter" @default.
- Q96811521 P2093 "Laurent Daniel Kremer" @default.
- Q96811521 P2093 "Marc Debouverie" @default.
- Q96811521 P2093 "Nicolas Collongues" @default.
- Q96811521 P2093 "Nicolas Meyer" @default.
- Q96811521 P2093 "Paulo Loureiro De Sousa" @default.
- Q96811521 P2093 "Thibault Tricard" @default.
- Q96811521 P304 "591" @default.
- Q96811521 P31 Q13442814 @default.
- Q96811521 P356 "10.1186/S13063-020-04517-6" @default.
- Q96811521 P433 "1" @default.
- Q96811521 P478 "21" @default.
- Q96811521 P577 "2020-06-29T00:00:00Z" @default.
- Q96811521 P698 "32600454" @default.
- Q96811521 P921 Q108853737 @default.
- Q96811521 P921 Q111908491 @default.
- Q96811521 P932 "7322908" @default.